Medical University of South Carolina
Charleston, South Carolina, 29425, United States
NCT Number: NCT04630249
Specific Aim 1: Conduct a pilot, small-scale randomized controlled trial to examine feasibility and preliminary efficacy of LTW, compared to TAU. Outcomes related to feasibility include percentage of eligible patients recruited, study attrition, study retention, and mental health and substance use treatment appointment attendance. Outcomes related to preliminary efficacy will include participation in screening, referral and treatment at baseline, compared to TAU.
Specific Aim 2: Conduct a randomized controlled trial to examine the effectiveness of LTW, compared to TAU. Outcomes related to effectiveness include screening, screening positive, referred to and attendance to treatment at baseline, compared to TAU.
Looking for future studies?
Notify Me18 year–41 year
Female
Interventional
Not applicable
Charleston, South Carolina, 29425, United States
Participants: 450 adult, pregnant or postpartum women
Intervention: Listening to Women is a mobile phone-based program designed to enhance delivery of Screening, Brief Intervention, and Referral to Treatment (SBIRT), an evidence-based approach for mental health and substance use screening and treatment for perinatal women. This program was created as a result of key informant interviews with obstetric providers and pregnant and postpartum women with opioid use disorders. The program utilizes mobile phone text message-based screenings with immediate automated feedback, paired with remote care coordination and, if appropriate, home-based telemedicine mental health and substance use disorder treatment services.
Design: Specific aim 1: A two arm pilot RCT (N=35) with 2:1 allocation will examine feasibility and preliminary efficacy of LTW, compared to TAU. Specific aim 2: A RCT (N=415) with 1:1 allocation will examine effectiveness of LTW, compared to TAU.
This study is part of the HEAL Initiative (https://heal.nih.gov/).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
None
Participants are enrolled in text message-based screenings with immediate automated feedback, paired with remote care coordination and, if appropriate, referral to telemedicine mental health and substance use disorder treatment services.
Time frame: Baseline
We will compare the proportion of participants that complete a screen for mental health and substance use among those assigned to LTWP, compared to TAU.
Time frame: Baseline
We will compare the proportion of those screening positive that are referred to treatment among those assigned to LTWP, compared to TAU.
Time frame: Baseline
We will compare the proportion of participants referred to treatment that had at least one mental health and/or substance use disorder treatment appointment among those assigned to LTWP, compared to TAU.
Time frame: Baseline
Treatment attendance (defined as attending at least 1 or more visits with a mental health and/or substance use disorder (SUD) treatment provider during pregnancy and the postpartum year)
Time frame: Baseline
Among those that completed a screen, proportion of participants that screened positive.
Time frame: Baseline
Among those that completed a screen, proportion of participants that were referred to treatment.
Time frame: Baseline
Among those that completed a screen, proportion of participants that attended a mental health or substance use treatment appointment.
Medical University of South Carolina
Other
Pilot RCT of Remote Mental Health and Substance Use Screening, Brief Intervention and Referral to Treatment (SBIRT), Compared to In-Person SBIRT for Peripartum Women
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06557005
Anxiety, Anxiety Disorders
Boston, Massachusetts, United States
View Trial DetailsNCT07483515
Anxiety, Anxiety Disorders
Singapore
View Trial DetailsNCT06788977
Anxiety, Anxiety Disorders
Darien, Connecticut, United States
View Trial DetailsNCT07066631
Anxiety, Anxiety Disorders
Toronto, Ontario, Canada
View Trial Details